COMMUNIQUÉS West-GlobeNewswire

Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines
28/08/2026
AUSTIN, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that [...]
Micron Biomedical Honored with Georgia Life Sciences' Prestigious Phoenix Award for Transformative Research
28/08/2026
An active CDC clinical trial of Micron’s rotavirus vaccine and Lancet-published research on Micron’s self-administered influenza vaccine, both conducted at Emory University, are highlighted in the recognition for [...]
Advocates to hold nationwide Day of Action for federal action to stop two-tier, American-style health care
28/08/2026
TORONTO, Aug. 28, 2026 (GLOBE NEWSWIRE) -- On Tuesday, September 1, health coalitions and allies across Canada will hold information pickets, rallies, and other actions in a National Day of Action to amplify our calls [...]
Minerva Neurosciences to Participate in Two Upcoming Investor Conferences
28/08/2026
BURLINGTON, Mass., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system [...]
ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split
28/08/2026
TYLER, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that a reverse stock split of the Company’s [...]
Glucose Health, Inc. (OTCID: GLUC) Appoints Consumer Products Industry Veteran John Duffy as Chief Executive Officer to Accelerate Growth, Elevate Brand Leadership, and Maximize Long-Term Shareholder Value
28/08/2026
Seasoned Consumer Packaged Goods Executive Brings More Than 20 Years of Senior Leadership at Coca-Cola Enterprises and The Coca-Cola Company to Lead Glucose Health's Next Phase of Strategic Expansion and Value Creation [...]
New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients
28/08/2026
Data Supports Approximately 30% Relative Risk Reduction Among Highly Adherent Patients and Provides Evidence Consistent with a Potential Legacy Effect in Secondary Prevention Patients After Treatment Discontinuation [...]
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
28/08/2026
Company Strengthens Global Intellectual Property Portfolio with 28 Issued and 30 Pending Patents DOYLESTOWN, Pa., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a [...]
INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
28/08/2026
Virtual company presentation will be available beginning September 11, 2026, at 7:00 a.m. ET SARASOTA, Fla., Aug. 28, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a [...]
DirectMeds Announces Expanded Access to Doctor-Guided GLP-1 Weight Management Programs Starting at $249 Per Month
28/08/2026
New York, NY, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Telehealth platform expands access to physician-guided GLP-1 treatment with transparent pricing, nationwide virtual care, and ongoing clinical support. DirectMeds today [...]
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
28/08/2026
Physician-Aligned Collaboration to Support a Regional Sleep & Airway Medicine Center in Palm Beach County LITTLETON, Colo., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or "the Company") ( [...]
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions
28/08/2026
$8 million senior secured ATW convertible note satisfied , together with all accrued interest, twelve months ahead of its August 2027 maturity and eliminating any further dilution Simplified capital structure , with no [...]
NeOnc’s Phase 2A Success Could Set the Stage for Something Much Bigger
28/08/2026
DENVER, Aug. 28, 2026 (GLOBE NEWSWIRE) -- For NeOnc Technologies Holdings (NASDAQ: NTHI) , the most important part of the NEO100 story may no longer be whether the company can produce a meaningful signal in recurrent [...]
CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026
28/08/2026
-Data presented in a late-breaking presentation at the European Society of Cardiology (ESC) Congress 2026- -Phase 1a clinical data for CTX310 ® continued to demonstrate robust, dose-dependent reductions in circulating [...]
EmblemHealth Helps New York City Students Start the School Year Strong
28/08/2026
EmblemHealth and local partners distributed thousands of backpacks, school supplies, and nutritious food to families across the five boroughs. PHOTO (Left to right): Council Member Sandra Ung, EmblemHealth VP Enterprise [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2026
28/08/2026
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les [...]
OSE Immunotherapeutics organisera un webcast dédié à lusvertikimab avec des leaders d’opinion le 2 septembre 2026
28/08/2026
NANTES, France, le 28 août 2026, 7h30 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) (la « Société ») , annonce aujourd’hui que la Société organisera un webcast avec des experts internationaux des [...]
OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026
28/08/2026
NANTES, France, August 28, 2026 – 7:30am CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (the "Company") , today announced that the Company will host a webcast with international experts in Inflammatory [...]
EssilorLuxottica annonce le lancement d’un programme de rachat d’actions
28/08/2026
EssilorLuxottica annonce le lancement d’un programme de rachat d’actions Paris, France (28 août 2026 – 8h00) – EssilorLuxottica annonce le lancement d’un programme de rachat d’actions qui traduit la confiance du Groupe [...]

Pages